Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Motor Activity 2 Stomach Neoplasms 1 Lung Neoplasms 1 Hodgkin Disease 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Disease 1 Colorectal Neoplasms 1

Interventions

Specimen Handling 52 Carboplatin 49 pembrolizumab 45 Magnetic Resonance Spectroscopy 44 Pemetrexed 39 Cisplatin 34 Paclitaxel 24 durvalumab 23 osimertinib 20 Nivolumab 19 Gemcitabine 19 Radiosurgery 17 Docetaxel 17 atezolizumab 15 Taxes 12 Radiotherapy 12 Immunoglobulin G 12 Disulfides 12 Biopsy 12 130-nm albumin-bound paclitaxel 12 Etoposide 11 Educational Status 11 Radiation 10 Drug Therapy 10 Blood Specimen Collection 10 Platinum 9 Early Intervention, Educational 9 Cetuximab 9 Methods 8 Bevacizumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × High-Intensity Interval Training × 90 days × Clear all

NCT06026111 2026-04-14

ENHANCE

Dana-Farber Cancer Institute

Phase NA Recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡